Characterization of ischemic heart disease at the XX Aniversary University Teaching Polyclinic, Santa Clara, Villa Clara
Keywords:
Ishemic heart disease; Risk factors; Myocardial infarction; Prevention; Treatment.Abstract
ABSTRACT
Introduction: Ischemic heart disease is the leading cause of death in Cuba and the world, and management of ist risk factors has proven to be effective.
Objective: To identify cardiovascular risk factors for ischeamic heart disease in adult patients at the XX Anniversary University Teaching Polyclinic in Santa Clara.
Methods: An epidemiological, analytical, and case-control study was carried out between May 2019 and February 2020 at the XX Anniversary University Teaching Polyclinic in the municipality of Santa Clara, Villa Clara. 840 subjects over 50 years of age were selected using probability and two-stage sampling. A multivariate logistic regression analysis was performed to determine the risk factors associated with ischemic heart disease.
Results: The most significant risk factors were: low fish intake (40,51 %), positive family history of ischemic heart disease (38,21 %), high consumption of animal fats (33,93 %), high wais/hip ratio and abdominal circumference (33,81 %).
Conclusions: The cardiovascular risk factors predicting ischemic heart disease with the greatest strength of association were: high consumption of animal fats, hypercholesterolemia, diabetes mellitus, low fish consumption, smoking, and a positive family history of ischemic heart disease.
Downloads
References
1. Reinikainen J, Kuulasmaa K, Oskarsson V, Amouyel P, Biasch K, Brenner H, et al. Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: an analysis of 49 cohorts from 11 European countries. Eur J Prev Cardiol. 2024;31(5):569-577. doi: 10.1093/eurjpc/zwad359. PMID: 37976098.
2. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191. Erratum in: Eur Heart J. 2024 Apr 1;45(13):1145. doi: 10.1093/eurheartj/ehad870. PMID: 37622654.
3. Ridker PM LP, Buring, JE. Marcadores de riesgo y prevención primaria de las enfermedades cardiovasculares. En: Zipes DP, et al. Braunwald Tratado de Cardiología. Texto de medicina cardiovascular. 12ma ed. España: ELSEVIER; 2023. p. 876-905.
4. Reyes S, Sánchez LS, del Puerto QC, Trujillo MM, Moreno CC, Cruz AA. Determinantes del estado de salud. En: Fundamentos de Salud Pública 2. La Habana, Cuba: Editorial Ciencias Médicas; 2005. p. 178.
5. Ordunez P, Tajer C, Gaziano T, Rodríguez YA, Rosende A, Jaffe MG. La aplicación HEARTS: una herramienta clínica para el manejo del riesgo cardiovascular y la hipertensión en la atención primaria de salud. Rev Panam Salud Publica. 2022;46:e46. doi: 10.26633/RPSP.2022.46. PMID: 35573118; PMCID: PMC9097924.
6. Noya ChM MG, Roca GR. ECIMED, La Habana, 2017. Vol I, p. 439. Roca Goderich. Temas de Medicina Interna. 5ta ed. La Habana, Cuba: Editorial Ciencias Médicas; 2017.
7. Gaviria S, Ramírez A, Alzate M, Contreras H, Jaramillo N, Muñoz MC. Epidemiología del síndrome coronario agudo. Medicina UPB. [Internet]. 2020 [citado 25 nov 2025];39(1):49-56. Disponible en: https://revistas.upb.edu.co/index.php/medicina/article/view/406
8. Dirección de Registros Médicos y Estadísticas de Salud, Ministerio de Salud Pública (CU). Anuario Estadístico de Salud 2023 [Internet]. 52.ª ed. La Habana: Ministerio de Salud Pública (CU); 2024 [citado 25 sep 2025]. 207 p. Disponible en: https://files.sld.cu/dne/files/2024/09/Anuario-Estad%c3%adstico-de-Salud-2023-EDICION-2024.pdf
9. Pan American Health Organization, World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. [Internet] 2000 [citado 24 nov 2025];894:i-xii, 1-253. Disponible en: https://iris.paho.org/handle/10665.2/43000 PubMed PMID: 11234459.
10. 1. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants. JAMA. 2025;333:71-4. doi:10.1001/jama.2024.21972
11. Vega AJ, Guimará MR, Garces HY,Vega AL, RM. Predicción de riesgo coronario y cardiovascular global en la atención primaria de salud. CCM. [Internet]. 2015 [citado 24 oct 2025];19(2).1-10. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812015000200003
12. Eduardo R, Valdés RA, Valdés EB, Valdés NB. Enfermedad cardiovascular aterosclerótica según el sexo en personas de edad mediana con diabetes mellitus. Rev Cuba Endocrinol. [Internet]. 2021 [citado 24 nov 2025];32(2):e303. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532021000200001
13. Reyes HL, Toledo PY, Bonilla NA, Gómez JR, Guerra GO. Enfoque clínico y epidemiológico del síndromecoronario agudo, una experiencia. Acta Méd Centro. [Internet]. 2019 [citado 14 oct 2025];13(1). Disponible en: https://revactamedicacentro.sld.cu/index.php/amc/article/view/917
14. Bonet GM, Varona PP. III Encuesta nacional de factores de riesgo y actividades preventivas de enfermedades no transmisibles. Cuba 2010-2011. Cuba: Editorial Ciencias Médicas; 2014. p. 172-92.
15. Álvarez AE. William Kannel y el estudio Framingham. Rev Cubana Med Milit. [Internet]. 2022 [citado 24 oct 2025]; 51 (2). Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1732
16. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. doi: 10.1001/jama.2013.284427. Erratum in: JAMA. 2014 May 7;311(17):1809. PMID: 24352797.
17. Rivera EL, Ledesma RS, López GR, Aguirre YP. Circunferencia abdominal y riesgo de enfermedad cardiovascular. Consultorio 22. Policlínico Docente “Aleida Fernández Chardiet”. 2016. Rev Haban Cienc Méd. [Internet]. 2018 [citado 20 nov 2025];17(4). 591-602. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2018000400591&lng=es.
18. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9. PMID: 15364185.
19. Lanas FA, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S. INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin America study. Circulation. [Internet]. 2007 [citado 20 mar 2025];115(9):1067-74. Disponible en:https://pubmed.ncbi.nlm.nih.gov/17339564/
20. Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177. Erratum in: Eur Heart J. 2025;46(16):1565. doi: 10.1093/eurheartj/ehaf079. PMID: 39210710.
21. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178. Erratum in: Eur Heart J. 2025;46(14):1300. doi: 10.1093/eurheartj/ehaf031. Erratum in: Eur Heart J. 2025;46(45):4949. doi: 10.1093/eurheartj/ehaf659. PMID: 39210715.
22. Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043-4140. doi: 10.1093/eurheartj/ehad192. Erratum in: Eur Heart J. 2023;44(48):5060. doi: 10.1093/eurheartj/ehad774. Erratum in: Eur Heart J. 2024;45(7):518. doi: 10.1093/eurheartj/ehad857. PMID: 37622663.
23. Bludorn J, Railey K. Hypertension Guidelines and Interventions. Prim Care. 2024;51(1):41-52. doi: 10.1016/j.pop.2023.07.002. PMID: 38278572.
24. Grillo Martín M, Mezquia de Pedro N, González García S. Tablas de predicción de riesgo cardiovascular empleadas en Cuba. Rev Cuba Cardiol Cir Cardiovasc. [Internet]. 2023 [citado 26 Nov 2025];29(1). Disponible en: http://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1408
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Jorge Mondeja Contino, Lisbet Cortés Gómez, Elibet Chávez González , Margarita Puerto Díaz, Liset Blay Gómez, Edward Bediako Mensah
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
